Literature DB >> 25066257

Most appropriate animal models to study the efficacy of statins: a systematic review.

Valentina Pecoraro1, Lorenzo Moja, Luigi Dall'Olmo, Glauco Cappellini, Silvio Garattini.   

Abstract

BACKGROUND: In animal models and clinical trials, statins are reported as effective in reducing cholesterol levels and lowering the risk of cardiovascular diseases. We have aggregated the findings in animal models - mice, rats and rabbits - using the technique of systematic review and meta-analysis to highlight differences in the efficacy of statins.
MATERIALS AND METHODS: We searched Medline and Embase. After examining all eligible articles, we extracted results about total cholesterol and other blood parameters, blood pressure, myocardial infarction and survival. Weighted and standard mean difference random effects meta-analysis was used to measure overall efficacy in prespecified species, strains and subgroups.
RESULTS: We included in systematic review 161 animal studies and we analysed 120 studies, accounting for 2432 animals. Statins lowered the total cholesterol across all species, although with large differences in the effect size: -30% in rabbits, -20% in mice and -10% in rats. The reduction was larger in animals fed on a high-cholesterol diet. Statins reduced infarct volume but did not consistently reduce the blood pressure or effect the overall survival. Few studies considered strains at high risk of cardiovascular diseases or hard outcomes.
CONCLUSIONS: Although statins showed substantial efficacy in animal models, few preclinical data considered conditions mimicking human pathologies for which the drugs are clinically indicated and utilized. The empirical finding that statins are more effective in lowering cholesterol derived from an external source (i.e. diet) conflicts with statin's supposed primary mechanism of action.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Animal models; hydroxymethylglutaryl-CoA reductase inhibitors; meta-analysis; statins; translational medical research

Mesh:

Substances:

Year:  2014        PMID: 25066257     DOI: 10.1111/eci.12304

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.

Authors:  Xiao-Ming Huang; Jia-Jun Huang; Jing-Jing Du; Na Zhang; Ze Long; You Yang; Fang-Fang Zhong; Bo-Wen Zheng; Yun-Fu Shen; Zhe Huang; Xiang Qin; Jun-He Chen; Qian-Yu Lin; Wan-Jun Lin; Wen-Zhe Ma
Journal:  Acta Pharmacol Sin       Date:  2021-02-19       Impact factor: 6.150

2.  Statin Therapy Alters Lipid Storage in Diabetic Skeletal Muscle.

Authors:  Irena A Rebalka; Matthew J Raleigh; Laelie A Snook; Alexandra N Rebalka; Rebecca E K MacPherson; David C Wright; Jonathan D Schertzer; Thomas J Hawke
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-19       Impact factor: 5.555

3.  Lovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null mice.

Authors:  Claudia Villani; Giuseppina Sacchetti; Renzo Bagnati; Alice Passoni; Federica Fusco; Mirjana Carli; Roberto William Invernizzi
Journal:  Elife       Date:  2016-11-28       Impact factor: 8.140

4.  Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.

Authors:  Irene Tramacere; Giorgio B Boncoraglio; Rita Banzi; Cinzia Del Giovane; Koren H Kwag; Alessandro Squizzato; Lorenzo Moja
Journal:  BMC Med       Date:  2019-03-26       Impact factor: 8.775

5.  Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice.

Authors:  Maria L Thomsen; Camilla Grønkjaer; Anna Iervolino; Soham Rej; Francesco Trepiccione; Birgitte M Christensen
Journal:  Physiol Rep       Date:  2021-11

6.  Hypercholesterolemia-Induced HDL Dysfunction Can Be Reversed: The Impact of Diet and Statin Treatment in a Preclinical Animal Model.

Authors:  Leonie Schoch; Pablo Sutelman; Rosa Suades; Laura Casani; Teresa Padro; Lina Badimon; Gemma Vilahur
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

Review 7.  Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies.

Authors:  Magda Dubińska-Magiera; Marta Migocka-Patrzałek; Damian Lewandowski; Małgorzata Daczewska; Krzysztof Jagla
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.